Study to Evaluate the Safety and Efficacy of KITE-585 in Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT03318861 · TERMINATED
Trial details
- NCT number
- NCT03318861
- Sponsor
- Kite, A Gilead Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-20
- Primary completion
- 2018-12-17
- Enrollment
- 17
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.